Matches in Wikidata for { <http://www.wikidata.org/entity/Q91528211> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q91528211 description "artículu científicu espublizáu en xunetu de 2019" @default.
- Q91528211 description "scientific article published on 01 July 2019" @default.
- Q91528211 description "wetenschappelijk artikel" @default.
- Q91528211 description "наукова стаття, опублікована 1 липня 2019" @default.
- Q91528211 name "Editor's Note: Cotreatment with STI-571 Enhances Tumor Necrosis Factor α-related Apoptosis-inducing Ligand (TRAIL or Apo-2L)-induced Apoptosis of Bcr-Abl-positive Human Acute Leukemia Cells" @default.
- Q91528211 name "Editor's Note: Cotreatment with STI-571 Enhances Tumor Necrosis Factor α-related Apoptosis-inducing Ligand (TRAIL or Apo-2L)-induced Apoptosis of Bcr-Abl-positive Human Acute Leukemia Cells" @default.
- Q91528211 type Item @default.
- Q91528211 label "Editor's Note: Cotreatment with STI-571 Enhances Tumor Necrosis Factor α-related Apoptosis-inducing Ligand (TRAIL or Apo-2L)-induced Apoptosis of Bcr-Abl-positive Human Acute Leukemia Cells" @default.
- Q91528211 label "Editor's Note: Cotreatment with STI-571 Enhances Tumor Necrosis Factor α-related Apoptosis-inducing Ligand (TRAIL or Apo-2L)-induced Apoptosis of Bcr-Abl-positive Human Acute Leukemia Cells" @default.
- Q91528211 prefLabel "Editor's Note: Cotreatment with STI-571 Enhances Tumor Necrosis Factor α-related Apoptosis-inducing Ligand (TRAIL or Apo-2L)-induced Apoptosis of Bcr-Abl-positive Human Acute Leukemia Cells" @default.
- Q91528211 prefLabel "Editor's Note: Cotreatment with STI-571 Enhances Tumor Necrosis Factor α-related Apoptosis-inducing Ligand (TRAIL or Apo-2L)-induced Apoptosis of Bcr-Abl-positive Human Acute Leukemia Cells" @default.
- Q91528211 P1433 Q91528211-30CD295E-237F-4C17-BDD8-17900F54B0FF @default.
- Q91528211 P1476 Q91528211-3342FE32-4CD4-4DCD-8313-0318FACBA0CF @default.
- Q91528211 P2093 Q91528211-32729D75-BB31-40C9-BE4C-E5328DC8DCE1 @default.
- Q91528211 P2093 Q91528211-5197D5F7-2EF9-4EF4-9A82-5A34D24DF11D @default.
- Q91528211 P2093 Q91528211-819C11AA-005B-44C1-BC83-2D829B2DB96C @default.
- Q91528211 P2093 Q91528211-DF19478B-2D19-4F83-801A-02B5564D46B6 @default.
- Q91528211 P2093 Q91528211-EE170659-04DE-42CD-BA89-9E4D2EEFEFBA @default.
- Q91528211 P2093 Q91528211-EE240AEC-9D61-454E-B058-7D49CE8743B1 @default.
- Q91528211 P2093 Q91528211-F5D5AA75-89CB-4926-A511-F1A235F92ADB @default.
- Q91528211 P304 Q91528211-E3483639-05F3-4DF7-A447-270EDD7BE157 @default.
- Q91528211 P31 Q91528211-D66E5107-9910-4F9F-9C21-E52E000CCA19 @default.
- Q91528211 P356 Q91528211-F2425DEC-9488-467E-A9BA-3EFC2EA2EFB8 @default.
- Q91528211 P433 Q91528211-E634EB7B-1C76-48C8-AC24-12612A606536 @default.
- Q91528211 P478 Q91528211-5E89D67E-42EA-45E0-80FB-51EBB45E657F @default.
- Q91528211 P577 Q91528211-7D3B2CDA-B813-436C-B3A0-3FE1883B25EF @default.
- Q91528211 P698 Q91528211-BF0CEC43-A5C3-43BD-A53C-89833C5B9CD0 @default.
- Q91528211 P921 Q91528211-4AA54984-9473-465C-80C3-BA61CE812265 @default.
- Q91528211 P356 1078-0432.CCR-19-1602 @default.
- Q91528211 P698 31263034 @default.
- Q91528211 P1433 Q332253 @default.
- Q91528211 P1476 "Editor's Note: Cotreatment with STI-571 Enhances Tumor Necrosis Factor α-related Apoptosis-inducing Ligand (TRAIL or Apo-2L)-induced Apoptosis of Bcr-Abl-positive Human Acute Leukemia Cells" @default.
- Q91528211 P2093 "Charles Perkins" @default.
- Q91528211 P2093 "Diep Nguyen" @default.
- Q91528211 P2093 "Elizabeth Worthington" @default.
- Q91528211 P2093 "Erica O'Bryan" @default.
- Q91528211 P2093 "Kapil Bhalla" @default.
- Q91528211 P2093 "Mercedes Porosnicu" @default.
- Q91528211 P2093 "Ramadevi Nimmanapalli" @default.
- Q91528211 P304 "4195" @default.
- Q91528211 P31 Q13442814 @default.
- Q91528211 P356 "10.1158/1078-0432.CCR-19-1602" @default.
- Q91528211 P433 "13" @default.
- Q91528211 P478 "25" @default.
- Q91528211 P577 "2019-07-01T00:00:00Z" @default.
- Q91528211 P698 "31263034" @default.
- Q91528211 P921 Q976388 @default.